Drug Screen for Cancer Patients Found
Posted on: Friday, 9 March 2007, 18:00 CST
Researchers at the University of Pennsylvania have found a way to screen cancer patients to see if they're suitable for a promising class of anti-cancer drugs.
The researchers propose screening cancer patients for proteasome inhibitors by testing for p53, a tumor-suppressor protein.
The anti-cancer proteasome inhibitors might be ineffective in patients whose tumors do not produce p53, said the researchers at the university's schools of medicine and veterinary medicine.
However, proteasome inhibitors are highly effective against lymphomas that do produce p53, the researchers said.
Proteasomes resemble paper shredders - they break down proteins such as p53 into smaller pieces, said associate pathology professor Andrei Thomas-Tikhonenko. A proteosome inhibitor effectively jams the shredder so that p53 is not immediately broken down.
The study appears online in the journal Blood , in advance of print publication in June 2007.
Source: United Press International
Related Articles
- Boehringer Ingelheim to Commence Phase III Study Investigating the Role of BIBW 2992 as First-Line Treatment for Non-Small Cell Lung Cancer (NSCLC) Patients with EGFR Mutations
- Philadelphia Cancer Patients to Benefit from Expansion of the American Cancer Society Patient Navigator Program
- Legacy Good Samaritan Hospital Surgeons Find BSGI Effective in Determining Extent of Breast Cancer in Patients With Known Diagnosis
- Aradigm Announces Data Showing No Occurrence of Primary Lung Cancer in Patients Treated With AERx(R) Insulin Diabetes Management System (iDMS)
- Delaware Cancer Patients Among Nation's First to Benefit From Expansion of the American Cancer Society's 'Patient Navigator Program'
- View Scientific Rationale for Novel Therapeutics in Lung Cancer, And the Results of Clinical Trials to Date Inside 'Triple Analysis: Non Small Cell Lung Cancer, Protein Kinase Inhibitors & Anti-Angiogenic Agents'
- Valeant Pharmaceuticals Announces Availability of Complimentary ``Managing Chemotherapy Side Effects For Dummies'' Cancer Chemotherapy Resource; Special Edition ``For Dummies''(R) Book Now Available for Cancer Chemotherapy Patients and Caregivers
- Geron Announces Publication of First In Vivo Data Demonstrating Efficacy of GRN163l in Models of Primary and Metastatic Breast Cancer; Results Corroborate Recent Research With Novel Telomerase Inhibitor in Other Cancer Types
- Nereus Pharmaceuticals Initiates Phase I Clinical Trial for Anti-Cancer Proteasome Inhibitor
- High-Tech Research Hospital Gives Patients a New Lease on Life
 |
 |
User Comments (0)
RSS Feeds